{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:47:42Z","timestamp":1693226862914},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijcard.2014.08.113","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T20:30:38Z","timestamp":1409430638000},"page":"527-528","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Isoprostane as a promising prognostic biomarker in pulmonary arterial hypertension: preanalytical and analytical viewpoints"],"prefix":"10.1016","volume":"177","author":[{"given":"Denis","family":"Monneret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Cracowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Bonnefont-Rousselot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcard.2014.08.113_bb0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2014.05.014","article-title":"Plasma 15-F2t-isoprostane in idiopathic pulmonary arterial hypertension","volume":"175","author":"Zhang","year":"2014","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2014.08.113_bb0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1378\/chest.11-1267","article-title":"Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension","volume":"142","author":"Cracowski","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2014.08.113_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ab.2013.12.030","article-title":"Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage","volume":"449","author":"Barden","year":"2014","journal-title":"Anal Biochem"},{"issue":"7","key":"10.1016\/j.ijcard.2014.08.113_bb0020","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.freeradbiomed.2007.12.026","article-title":"Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample","volume":"44","author":"Lee","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.ijcard.2014.08.113_bb0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/rcm.4871","article-title":"Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography\/tandem mass spectrometry cannot be compared","volume":"25","author":"Klawitter","year":"2011","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"4","key":"10.1016\/j.ijcard.2014.08.113_bb0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.diabet.2014.05.006","article-title":"Isoprostane as oxidative stress biomarker in the VARIAFIT study: analytical and methodological considerations","volume":"40","author":"Monneret","year":"2014","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.ijcard.2014.08.113_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-4347(00)00201-2","article-title":"Rapid and sensitive quantification of 8-isoprostaglandin F2alpha in human plasma and urine by liquid chromatography\u2013electrospray ionization mass spectrometry","volume":"746","author":"Ohashi","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"2","key":"10.1016\/j.ijcard.2014.08.113_bb0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2006.074989","article-title":"Isoprostane measurement in plasma and urine by liquid chromatography\u2013mass spectrometry with one-step sample preparation","volume":"53","author":"Sircar","year":"2007","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.ijcard.2014.08.113_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchromb.2008.02.019","article-title":"Determination of 8-iso-prostaglandin F(2alpha) in exhaled breath condensate using combination of immunoseparation and LC\u2013ESI\u2013MS\/MS","volume":"867","author":"Syslov\u00e1","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314016581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314016581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T05:24:38Z","timestamp":1538285078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314016581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0167527314016581"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.08.113","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoprostane as a promising prognostic biomarker in pulmonary arterial hypertension: preanalytical and analytical viewpoints","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.08.113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}